Download Krishna Patel, MD, PhD, Hemangioma Vascular Malformation

for the Women & Children’s Hospital Medical Staff
Volume 6 • Issue 19 • May 12, 2016
Grand Rounds for the Week of May 15, 2016 OB‐GYN: Tuesday May 17, 2016 7:30 a.m. CSB 628 Topic: “Cranky Vulvas and a Solution for Painful Sex in Postmenopause” Speaker: Dr. Martha Goetsch Oregon Health & Science PEDIATRICS: PEDIATRICS: 8:00 a.m. Storm Eye Auditorium Friday, May 13, 2016 Topic: “Gender Dysphoria” Speaker: Deborah Bowlby, MD Division Chief, Pediatric Endocrinology Friday, May 20, 2016 TBD Volume 6 • Issue 19 May 12, 2016 MUSC Hemangioma Vascular Malformation Treatment Program (HVMTP) – TEAM MEMBERS: Dr. Marcelo Hochman, Plastic Surgery Dr. Lara Wine Lee, Ped Dermatology Dr. Aaron Lesher, General Pediatric Surgery Dr. Krishna Patel, Ped ENT Dr. David White, Ped ENT For an Appointment, Please Call: (843) 876‐2609 Facts FAX Team:
Dr. Rita M. Ryan, MD
Linda Howard
Robin Rose
Amy Hauser
Scott Russell, MD
Suzanne Scott
Krishna Patel, MD, PhD, Hemangioma Vascular Malformation Treatment Program (HVMVP)
The MUSC Hemangioma Vascular Malformation Treatment Program (HVMTP) is a team of physicians from multiple subspecialties. We treat patients with challenging vascular anomalies. Vascular anomalies are a diverse group of disorders that include: • Hemangiomas • Vascular Malformations o Lymphatic malformations o Arteriovenous malformation o Venous malformations o Capillary malformations (port wine stain, others) Because many of these anomalies represent lifelong disease, patients often require multiple treatments that range from medical management with conventional medications and/or chemotherapeutic agents, surgical procedures, and interventional radiology procedures. The specialists at our MUSC Hemangioma Vascular Malformation Treatment Program are very experienced in diagnosing and treating vascular anomalies. Proper diagnosis is imperative because the treatment options for hemangiomas and vascular malformations can vary widely. FACTS: • Correct diagnosis of the lesion is 90% accurate by thorough history and physical exam alone. • Hemangiomas  10% incidence by 1 year of age.  Not all hemangiomas are the same in behavior or treatment.  Many hemangiomas do not disappear with age.  Hemangiomas in the head and neck region can cause substantial complications of vision, airway/swallowing, and cosmesis.  Propranolol has become the gold standard for treating infantile hemangiomas and is FDA approved. • Venous Malformations  Incidence 1‐4 %  Common treatments include sclerotherapy and surgical excision • Lymphatic malformations  Incidence 1‐2.8%  Can be mixed lesions with venous malformations  Common treatments include sclerotherapy and surgical excision Monthly Team Meetings: o Our team of specialists meet monthly to discuss patients in a multidisciplinary forum. o This allows the team to make a comprehensive treatment plan for patients to address their individual needs. o Meetings are open to any medical subspecialist interested in participating. FOR AN APPOINTMENT or to REQUEST PATIENT CASE PRESENTATION PLEASE CALL: Dr. Lara Wine Lee, Pediatric Dermatology‐ 843‐876‐2609